IMMUTEP LTD ORDINARY (IMM) Short Interest

IMMUTEP LTD ORDINARY (ASX:IMM) had 2.39% of shares reported as short positions as of 4 June 2026, representing 35,230,630 shares. IMMUTEP LTD ORDINARY operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).

Short interest
2.39%
Reported positions
35,230,630
Industry
Pharmaceuticals, Biotechnology & Life Sciences
As of
4 June 2026

Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.

Immutep logo

IMM

Immutep

Pharmaceuticals, Biotechnology & Life Sciences

Immutep is a biotechnology company focused on developing LAG-3 related immunotherapy products for the treatment of cancer and autoimmune diseases. The company is pioneering the LAG-3 space and has clinical-stage assets targeting areas of high unmet need.

biotechnology
pharmaceuticals
immunotherapy
oncology

Shorted

short percentage2.39%
reported shorts35.2M
shares on issue1.474B